3519 results for «2008»

Filter By

3519 results

Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

01 Sep 2022

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Daniele Giacoppo

Author

Daniele Giacoppo
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Planning treatment strategies in multivessel disease

18 May 2022 – From EuroPCR 2022

Physiology and imaging are important tools to use in the cathlab: thanks to this seminar, learn how to use them at best, by analysing their impact on the case of a 66-year-old female patient with diabetes, hypertension, hyperlipidemia, left carotid surgery in 2008, admitted in April...

Planning treatment strategies in multivessel disease - Day #2 Seminar #2

CAD and TAVI

18 Feb 2024 – From PCR Tokyo Valves 2024

What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...

CAD and TAVI

Factors to consider during lifetime planning for TAVI patients

19 Feb 2023 – From PCR Tokyo Valves 2023

In this session, explore factors influencing lifetime prognosis and complication avoidance strategies in TAVI patients, focusing on pacemaker and paravalvular leak risk factors.

My worst nightmare in TAVI

Listen to our experts share their most nightmarish TAVI cases and follow the debate around their treatments. For instance, would you make the same choices when faced with a 76-year-old female patient diagnosed as severe AS, transferred for SAVR/TAVI, who got a new Abif and cardiogenic...

My worst nightmare in TAVI

Case-based challenging TAVI

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations. 

Case-based challenging TAVI

Contemporary procedural practice for TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to learn more about contemporary procedural practice for TAVI: discover the impact of the COVID-19 pandemic on TAVI programmes worldwide, the steps of contemporary transfemoral TAVI with tips and tricks, as well as the rules for early discharge post TAVI.

Contemporary procedural practice for TAVI

Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.

Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion

Selection of the 2023 best clinical cases

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore the most outstanding clinical cases from PCR Tokyo Valves 2023, including a delayed left ventricular rupture after transcatheter edge-to-edge mitral valve repair and successful bailouts in transcatheter mitral valve repair.

Lifetime management of patients with aortic stenosis and expanding indication of TAVI - What do we need to know next?

TAVI patients are getting younger and younger, and are becoming less and less risky, so it is becoming essential to know how to manage lifetime and follow-up of patients with aortic stenosis, how to manage prosthesis degeneration, and perform TAVI-in-TAVI or TAVI explant. Thanks to this...

Lifetime management of patients with aortic stenosis and expanding indication of TAVI - What do we need to know next?

Coronary access after TAVI: timing and techniques

09 Feb 2025 – From PCR Tokyo Valves 2025

Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:

  • Case 1: Managing a patient with...
Coronary access after TAVI: timing and techniques

Nightmare in TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...

Nightmare in TAVI

Combined valve disease

09 Feb 2025 – From PCR Tokyo Valves 2025

This session delves into the management of combined valve disease, covering topics such as transcatheter tricuspid valve replacement and valve-in-valve/valve-in-ring implantation in high-risk patients, the importance of CT imaging analysis in predicting true mitral stenosis in TAVI patients, the clinical outcomes of mild-to-moderate mixed aortic valve...

Combined valve disease

Lessons from OCEAN registry

16 Feb 2019 – From PCR Tokyo Valves 2019

Consult this session to learn more about the current status and future perspectives of the OCEAN-TAVI registry, as well as the differences between European and Japanese anatomies.

Lessons from OCEAN registry

Most challenging cases with SAPIEN3 Vol I – access, anatomy and heart function

16 Feb 2019 – From PCR Tokyo Valves 2019

Consult this session to discover challenging cases with SAPIEN3, including horizontal aorta, low laying coronaries and low ejection fraction.

Most challenging cases with SAPIEN3 Vol I – access, anatomy and heart function

Prosthesis-patient mismatch after TAVI – what is the impact?

17 Feb 2019 – From PCR Tokyo Valves 2019

Consult this session to learn more about the impact regarding Prosthesis-Patient Mismatch after TAVI, the possible TAVI risks in small anatomy patients, and discover the options to prevent PPM after TAVI.

Prosthesis-patient mismatch after TAVI – what is the impact?

Rapid-fire - Bailout in TAVI

18 Feb 2024 – From PCR Tokyo Valves 2024

As TAVI is never risk-free, learn about bailout techniques to counter various complications through this series of rapid-fire case submissions. This session explores cases such as a transcatheter aortic valve distortion following cardiopulmonary resuscitation, acute transcatheter aortic valve migration into the left ventricle, and valve embolization.

Rapid-fire - Bailout in TAVI

TAV-in-TAV interventions: a new frontier in TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...

TAV-in-TAV interventions:

Bicuspid valves - Imaging, sizing and technical considerations for success

18 Feb 2023 – From PCR Tokyo Valves 2023

Watch this session to learn more about bicuspid aortic valves: understand the anatomical considerations that define patient selection, explore contemporary sizing strategies and participate in case-based discussions that highlight treatment strategies for bicuspid aortic stenosis.

Late-Breaking Trial session

08 Feb 2025 – From PCR Tokyo Valves 2025

Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...

Late-Breaking Trial session
Didn’t find what you were looking for?